Institutional members access full text with Ovid®

A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease

Gabriel, Iana; Apperley, Janea; Bower, Markb; Chaidos, Aristeidisa; Gazzard, Brianc; Giles, Chrissya; Kew, Andreaa; Nelson, Markc; Kanfer, Eda

doi: 10.1097/QAD.0b013e3282f0e3e5
Research Letters

A 44-year-old man with relapsed HIV-associated stage IV nodular sclerosing Hodgkin's disease underwent high-dose therapy with autologous stem cell transplantation. The transplant was uncomplicated and the patient remains in complete remission at 59 months. Autologous stem cell transplantation is safe in HIV patients and can achieve long-term durable remissions in Hodgkin's disease.

aDepartment of Clinical Haematology, Hammersmith Hospital, London, UK

bDepartment of Clinical Oncology, Chelsea and Westminster Hospital, London, UK

cDepartment of HIV Medicine, Chelsea and Westminster Hospital, Centre for Infections, Health Protection Agency, London, UK.

Received 27 April, 2007

Accepted 27 April, 2007

© 2008 Lippincott Williams & Wilkins, Inc.